JLE

Hépato-Gastro & Oncologie Digestive

MENU

Endoscopic retrograde cholangiopancreatography: for which scope in 2013? Volume 20, issue 4, Avril 2013

Figures

See all figures

Authors
Hôpital de la Conception, service d’hépato-gastroentérologie, 147 boulevard Baille, 13005 Marseille, France

Endoscopic retrograde cholangiopancreatography (ERCP), despite its morbidity, remains an essential exploration to investigate biliary and pancreatic diseases. The diagnostic interest has been competed by improvement of less invasive imaging methods (MRI, CTscan, endo-ultrasonography). The scope of ERCP has become almost exclusively therapeutic. Improvement of techniques and equipment allows treating affections previously reserved for surgery. What is new is the prevention of post ERCP acute pancreatitis, treatment of biliary stones (whose demand is expected to increase with population aging) and the development of full-covered metallic stents?